Chilblain lupus-like cutaneous reaction associated with systemic lupus erythematosus induced by immune checkpoint inhibitor.

Takeda, Koichi; Nakano, Kenji; Udagawa, Shohei; Fukuda, Naoki; Nishizawa, Aya; Ono, Makiko; Urasaki, Tetsuya; Tomomatsu, Junichi; Mochizuki, Toshiaki; Shiga, Taro; Kogawa, Takahiro; Takahashi, Shunji; Kitano, Shigehisa

Takeda, Koichi; Nakano, Kenji; Udagawa, Shohei; Fukuda, Naoki; Nishizawa, Aya; Ono, Makiko; Urasaki, Tetsuya; Tomomatsu, Junichi; Mochizuki, Toshiaki; Shiga, Taro; Kogawa, Takahiro; Takahashi, Shunji; Kitano, Shigehisa.

Affiliation

Takeda K; Department of Onco-Rheumatology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
Nakano K; Department of Infectious Diseases, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
Udagawa S; Department of Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
Fukuda N; Department of Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
Nishizawa A; Department of Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
Ono M; Department of Dermatology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
Urasaki T; Department of Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
Tomomatsu J; Department of Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
Mochizuki T; Department of Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
Shiga T; Department of Emergency Medicine, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
Kogawa T; Department of Onco-Cardiology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
Takahashi S; Division of Early Clinical Development for Cancer, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
Kitano S; Department of Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.

Rheumatology (Oxford) ; 61(1): e13-e14, 2021 12 24.

Article de En | MEDLINE | ID: mdl-34463707

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Lupus érythémateux cutané / Érythème pernio / Anticorps monoclonaux humanisés / Inhibiteurs de points de contrôle immunitaires Type d'étude: Risk_factors_studies Limites: Female / Humans / Middle aged Langue: En Journal: Rheumatology (Oxford) Sujet du journal: REUMATOLOGIA Année: 2021 Type de document: Article Pays d'affiliation: Japon

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google